Trial Profile
Efficacy in the central nervous system (CNS) of two combination regimens with different penetration rank in HIV-positive naive patients
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2018
Price :
$35
*
At a glance
- Drugs Abacavir (Primary) ; Lopinavir/ritonavir (Primary) ; Atazanavir; Emtricitabine/tenofovir disoproxil fumarate; Ritonavir
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms SNC
- 08 Dec 2018 Status changed from recruiting to discontinued.
- 23 Mar 2012 New trial record